Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine and Apixaban: Analysis of Physiological Parameters for the Prevention of Complications in Patients With Infection With the New Coronavirus (Covid-19). A Randomized Clinical Trial

NCT04788355 is registered in ClinicalTrials.gov with Universidade do Vale do Sapucai as lead sponsor.

NCT NCT04788355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04788355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine and Apixaban: Analysis of Physiological Parameters for the Prevention of Complications in Patients With Infection With the New Coronavirus (Covid-19). A Randomized Clinical Trial
Lead sponsor
Universidade do Vale do Sapucai
Phase
Phase 3
Overall status
Completed
Start date
July 1, 2020
Completion date
December 23, 2020
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complication